Company Overview of N-Gene Research Laboratories, Inc.
N-Gene Research Laboratories, Inc. operates as a diabetes research biopharmaceutical company. It focuses in the areas of metabolic disorders. The company’s product include BGP-15, an oral anti-diabetic drug with added cardiovascular and metabolic benefits for use in the treatment of Type 2 diseases, monotherapy, and combination disorders; and anti-schizophrenics, insulin resistance attenuation, and weight gain disorders. It also engages in clinical trials. The company was founded in 1997 and is based in New York, New York.
575 Madison Avenue
New York, NY 10022
Founded in 1997
Key Executives for N-Gene Research Laboratories, Inc.
Similar Private Companies By Industry
|Amerimmune Pharmaceuticals Inc.||United States|
|Juniper Medical, Inc.||United States|
|ReceptoPharm, Inc.||United States|
|Innovative Biologics, Inc.||United States|
|Adjuvance Technologies, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact N-Gene Research Laboratories, Inc., please visit www.ngene.us. Company data is provided by Capital IQ. Please use this form to report any data issues.